Novo Integrated Sciences, Inc. (NVOS)
NASDAQ: NVOS · IEX Real-Time Price · USD
0.665
+0.063 (10.41%)
At close: Jul 19, 2024, 12:00 AM
0.604
-0.061 (-9.22%)
Pre-market: Jul 22, 2024, 9:15 AM EDT
Novo Integrated Sciences Employees
As of August 31, 2023, Novo Integrated Sciences had 230 total employees, including 127 full-time and 103 part-time employees. The number of employees increased by 24 or 11.65% compared to the previous year.
Employees
230
Change (1Y)
24
Growth (1Y)
11.65%
Revenue / Employee
$58,769
Profits / Employee
-$105,778
Market Cap
12.67M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Ontrak | 104 |
STRATA Skin Sciences | 99 |
Check-Cap | 85 |
Aptose Biosciences | 36 |
Lumos Pharma | 33 |
Purple Biotech | 20 |
NEXGEL | 19 |
GeoVax Labs | 17 |
NVOS News
- 2 days ago - Novo Integrated Sciences Reports Fiscal Year 2024 Third Quarter Financial Results - Business Wire
- 2 days ago - What's Going On With Novo Integrated Sciences Stock On Friday? - Benzinga
- 3 days ago - Novo Integrated Sciences Receives Commencement of Disbursement Notice for SBLC Leasing and Monetizing Program - Business Wire
- 5 weeks ago - Novo Integrated Sciences Receives Confirmation of Issuance of SBLC by HSBC for SBLC Leasing and Monetizing Program - Business Wire
- 6 weeks ago - Novo Integrated Sciences' Board of Directors Approves Increase of Maximum Amount Under Stock Repurchase Program to $10 Million - Business Wire
- 6 weeks ago - Acenzia Selected to Participate in Protein Industries Canada Program to Develop Plant Based Protein Products - Business Wire
- 6 weeks ago - Novo Integrated Sciences and RC Consulting Consortium Group Amend $70,000,000 Promissory Note - Business Wire
- 6 weeks ago - KBRA Assigns AA- to Pennsylvania Turnpike Commission Turnpike Revenue Bonds, Series C of 2024; Affirms Related Ratings - Business Wire